A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients

Multiple Sclerosis

Volumn 14, Issue 4, 2008, Pages 500-505

  Sauter, Cornelia ^a,b   Zebenholzer, K ^a   Hisakawa, J ^c   Zeitlhofer, J ^a   Vass, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Fonds Soziales Wien   (Austria)

Author keywords

Depression; Fatigue management; Multiple sclerosis; Sleep quality

Indexed keywords

IMMUNOMODULATING AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; ENERGY CONSERVATION; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MULTIPLE SCLEROSIS; PATIENT PARTICIPATION; PHYSICAL DISABILITY; PSYCHOSOCIAL DISORDER; RATING SCALE; SELF CONCEPT; SLEEP DISORDER;

DEPRESSION; DISABILITY EVALUATION; ENERGY METABOLISM; FATIGUE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MULTIPLE SCLEROSIS; OCCUPATIONAL THERAPY; PATIENT EDUCATION AS TOPIC; PROGRAM EVALUATION; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; SLEEP; TREATMENT OUTCOME;

EID: 46749109179     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507084649     Document Type: Article

References (34)

1. Krupp L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. Mult Scler 2006; 12: 367-8.
2. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14.
3. Iriarte J, Subira ML, Castro P. Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors. Mult Scler 2000; 6: 124-30.
4. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988; 45: 435-7.
5. Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X. Fatigue in multiple sclerosis persists over time: A longitudinal study. J Neurol 2006; 253: 1466-70.
6. Chwastiak LA, Gibbons LE, Ehde DM, Sullivan M, Bowen JD, Bombardier CH et al. Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res 2005; 59: 291-8.
7. Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler 2005; 11: 602-9.
8. Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality and behavior change. J Neurol Sci 2005; 231: 29-34.
9. Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klosch G, Kollegger H et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 2004; 110: 6-13.
10. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler 2003; 9: 219-27.
11. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 2006; 243: 39-45.
12. Voss WD, Arnett PA, Higginson CI, Randolph JJ, Campos MD, Dyck DG. Contributing factors to depressed mood in multiple sclerosis. Arch Clin Neuropsychol 2002; 17: 103-15.
13. MacAllister WS, Krupp LB. Multiple sclerosis-related fatigue. Phys Med Rehabil Clin N Am 2005; 16: 483-502.
14. Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 2005; 64: 1139-43.
15. Rosenberg JH, Shafor R. Fatigue in multiple sclerosis: a rational approach to evaluation and treatment. Curr Neurol Neurosci Rep 2005; 5: 140-6.
16. Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A et al. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci 2004; 218: 103-8.
17. Taus C, Giuliani G, Pucci E, D'Amico R, Solari A. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2003: CD002818.
18. Mathiowetz VG, Finlayson ML, Matuska KM, Chen HY, Luo P. Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler 2005; 11: 592-601.
19. Packer TL, Brink N, Sauriol A. Managing fatigue. A six-week course for energy conservation. Arizona: Therapy Skill Builders Tuscon, 1995.
20. Finlayson M. Pilot study of an energy conservation education program delivered by telephone conference call to people with multiple sclerosis. NeuroRehabilitation 2005; 20: 267-77.
21. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FB et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International panel of the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-52.
23. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-3.
24. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-50.
25. Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline and placebo. Neurology 1995; 45: 1956-61.
26. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis. Evidence-based management strategies for fatigue in multiple sclerosis. Multiple Sclerosis Council for Clinical Practice Guidelines and Paralyzed Veterans of America Washington, 1998.
27. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
28. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
29. Ward N, Winters S. Results of a fatigue management programme in multiple sclerosis. Br J Nurs 2003; 12: 1075-80.
30. Mathiowetz V, Matuska KM, Murphy ME. Efficacy of an energy conservation course for persons with multiple sclerosis. Arch Phys Med Rehabil 2001; 82: 449-56.
31. Vanage SM, Gilbertson KK, Mathiowetz V. Effects of an energy conservation course on fatigue impact for persons with progressive multiple sclerosis. Am J Occup Ther 2003; 57: 315-23.
32. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: Initial validation of the Fatigue Impact Scale. Clin Infect Dis 1994; 18: 79-83.
33. Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X. Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler 2005; 11: 198-202.
34. Flachenecker P, Kumpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002; 8: 523-6.